Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

CHIEF FINANCIAL OFFICER Cline Christopher R. sold $42,610 worth of shares (642 units at $66.37), decreasing direct ownership by 0.54% to 118,016 units (SEC Form 4) to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.